Shilpa Medicare has informed that the Company has completed USFDA audit at its API site, Raichur between 22nd July 2019 and 26th July 2019. The Company has received Form 483 with 5 observations, with no repeat observations and any data integrity observations. The observations are mostly procedural in nature.
The above information is a part of company’s filings submitted to BSE.